The shifting landscape amid China's biotech rises presents both opportunities and geopolitical challenges for growth strategies.
Monica Gorman, PhD
Advertisement
Managing Director, Crowell Global Advisors
Articles by Monica Gorman, PhD
When Borders Become Bottlenecks: How Pharma Should Adapt to the New Geopolitical Lens
Published: | Updated:
Welcome to Pharm Exec's new guest column on navigating the geopolitical risks challenging core company strategies in today's shifting global landscape for healthcare.
A proactive strategy that promotes U.S. pharmaceutical manufacturing is a crucial pillar within a resilient and diversified supply chain ecosystem.
Advertisement
Latest Updated Articles
When Borders Become Bottlenecks: How Pharma Should Adapt to the New Geopolitical LensPublished: December 8th 2025 | Updated: December 11th 2025
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Leading in the Psychedelic Space: Q&A with Tarek Rabah
5